Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 92 days ( -1.68 % )
Last Price $9.09 0 %
High/ Low $9.09 - $9.09 0%
Chg 7 Days N/A $9.09 $9.09
Chg 30 Days N/A $9.09 $9.09
Chg 12 mos 56.99 % $5.79 $9.09
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos 80.22 % Width: 74.85 %
Pred. range - 3 mos $9.09 - $9.09 0 % - 0 %
Pred. range - 12 mos $11.54 - $20.17 26.90 % - 121.88 %
Short MA avg 3 mos Sell 2023-06-27 - 61 days
Long MA avg 3 mos Sell 2023-08-07 - 33 days
Short/Long MA avg 3 mos Sell 2023-08-07 - 33 days
Short MA avg 12 mos Sell 2023-07-18 - 47 days
Long MA avg 12 mos Buy 2023-05-09 - 94 days
Short/Long MA avg 12 mos Buy 2023-05-10 - 93 days
Pivot Short Sell 2023-09-20 - 2 days
Bollinger Sell 0000-00-00 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About CTI BioPharma Corp.

CTI BioPharma CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients with myelofibrosis. It has license and collaboration agreement with Teva Pharmaceutical Industries Ltd.;... CTIC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT